More medtech trends
Nanotechnology advances. The use of nanotechnology in medicine has faced as many overblown promises as any other application of nanotechnology. However, any realistic view of future medical technologies with big impact would be amiss if it did not consider the myriad applications of "nanotechnology", which we place in quotes to denote that there [...]
Obesity puts a burden on so many aspects of life that the socioeconomic cost is almost inevitably enormous—as well as very difficult to accurately pin down. At the individual level, there is the lower quality of life, days missed from work, decreased wages, premature retirement, potentially unemployment, and the medical costs of related illnesses, which [...]
[Healthcare costs have two important components -- the cost of treating diseases and the costs of not treating them. In the din of discussion of rising healthcare costs, frequently the mantra is heard that medical technology is responsible for the higher costs. Yet, in the case of chronic diseases, the associated, preventable complications, which can run the gamut [...]
While this is separately a White Paper that I wrote and periodically re-write to reflect new stuff being developed (or progressing in that development), it is worthwhile to occasionally revisit the list of technologies that have real promise, especially if that promise is getting closer to reality, or only if the demand is simply getting [...]
As I am occasionally known to do, I am providing the list of actual company names recently identified as medtech startups (and included in the Medtech Startups Database). See below:
Tissue Fusion, LLC (laser devices to “weld” biological tissues together for wound closures)
Applied Catheter Technologies, Inc. (drug-coated urinary and other catheters and stents that are designed [...]
There is certainly the possibility (despite my doubts) that the current economic slowdown in global markets will have major effects on the medical technology industry. One simply cannot deny that there is simply less VC or other cash floating around that might be put to medtech investment. And maybe, as has occurred in [...]
